A major diplomatic rupture is unfolding between Washington and Pretoria as the United States moves to halt HIV and Aids funding to South Africa — a decision that threatens one of the world’s largest public‑health programmes and exposes deepening political tensions between the two nations. The announcement has sent shockwaves through global health circles and raised urgent questions about the future of HIV treatment for millions of South Africans.
More than eight million South Africans are living with HIV — the highest number in the world — and Pepfar has been contributing around $400 million (£300 million) annually until 2025. The US now argues that “South Africa is a middle-income country and is more than capable of supporting its own health programs,” a stance that has sparked alarm among health experts and civil society organisations.
The State Department appeared to connect the funding halt to South Africa’s alleged failure to protect the white‑minority Afrikaner community — an allegation the South African government has repeatedly rejected. The White House also cited “unjust and immoral practices,” pointing to South Africa’s Black Economic Empowerment policies, its case against Israel at the International Court of Justice, and its diplomatic ties with Iran, ValidViewNetwork reports.
ValidViewNetwork reports that the US government has confirmed a “phased drawdown” of Pepfar funding, ending nearly two decades of large‑scale American support for South Africa’s HIV response.
ValidViewNetwork reports that the State Department linked the decision to “South Africa’s failure to make demonstrable progress on policy requests by the administration.”
South Africa’s health ministry said it had not been formally notified of the decision but noted it had “long been working on a self-reliance plan.” Officials stressed that while Pepfar supported parts of the HIV response, the provision of life‑saving antiretroviral drugs is funded separately, largely by the government, ValidViewNetwork reports.
Relations between the two countries have deteriorated sharply since the inauguration of President Donald Trump. Early in his term, Trump issued an executive order alleging that “countless” South African policies dismantled equal opportunities and fuelled violence “against racially disfavored landowners.” Pretoria disputes this, arguing that Black Economic Empowerment is essential to correcting apartheid‑era inequalities.
Trump has also alleged that a “white genocide” is taking place in South Africa , a claim widely discredited by researchers and human rights groups. The administration subsequently created a refugee programme specifically for Afrikaners, who are now among the only refugees being admitted into the United States.
Attempts to repair relations have repeatedly failed. Even a high‑profile White House meeting between Trump and President Cyril Ramaphosa did little to ease tensions, with Trump reportedly confronting Ramaphosa over claims of white persecution. The US later boycotted the G20 meeting hosted by South Africa last November.
As the US withdraws one of the most significant HIV funding streams on the planet, South Africa faces a defining moment , one that will test its public‑health resilience and its diplomatic footing on the global stage. The political rift behind the decision has exposed deep fractures that could reshape international partnerships for years to come. Whether this marks a temporary rupture or a long‑term realignment, the consequences will be felt far beyond the halls of government.
Do you want to advertise with us?
Do you need publicity for a product, service, or event?
Contact us on WhatsApp +2348033617468, +234 816 612 1513, +234 703 010 7174
or Email: validviewnetwork@gmail.com
CLICK TO JOIN OUR WHATSAPP GROUP


